NanovelosS.A.Active
Research and experimental development in natural sciences and engineering
KRS: 0000581695 NIP: 9522123769 REGON: 14659524700000
Overview
Registry date
2015-10-30
Share capital
$272,881.74
Activity description
Nanovelos is a biotechnology company specializing in the use of nanotechnology for oncological therapies. It develops polysaccharide-based drug carriers aimed at precise drug delivery for cancer treatment, specifically working on an effective drug using epirubicin (PolEpi) for ovarian cancer therapy. The company's technology aims to enhance treatment efficacy while minimizing adverse effects on patients.
Registered address
Ul. Rakowiecka 36, 02-532 Warszawa, Poland
Website
nanovelos.comWebsite active
Electronic delivery address
AE:PL-17008-17306-VSFEJ-20
Accounts
Registered as a VAT taxpayer on 2013-04-25.Active
- 88 1090 1056 0000 0001 2050 0979
- 54 1090 1056 0000 0001 4676 5214
- 14 1090 1056 0000 0001 3508 2090
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Real ResearchS.A. | $565,296.66 | real-research.com/ | |
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | |
| PolbionicaS.A. | $225,022.81 | polbionica.com/ | |
| NanosanguisS.A. | $133,800.85 | nanosanguis.com | |
| SatroecgS.A. | $117,301.57 | satroecg.pl | |
| Smart FluidS.A. | $100,333.00 | smartfluid.pl | |
| ARES Shield AiS.A. | $21,335.85 | aresshield.ai | |
| NanotheaS.A. | $12,468.28 | nanothea.com | |
| IncellvuS.A. | $6,985.93 | incellvu.pl | |
| MolecureS.A. | $10.77 | molecure.com |
FAQ
Last updated: 2026-07-16